• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX 2.71% $15.89

TELIX PHARMACEUTICALS LIMITED

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TLX
Short Term trading, analysis and TLX noise - No investors keep out
6 7 8
17:23 420 130K
17:23 Last post  drg Comments Created with Sketch.  420  Views Created with Sketch.  130K 
TLX 15:50 23 5.9K
15:50 Last post  ablackcockatoo Comments Created with Sketch.  23  Views Created with Sketch.  5.9K 
TLX
Understanding Telix
14 15 16
13:16 932 419K
TRENDING NEWS

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

NEWS
27 May 2024
13:16 Last post  gingerclam Comments Created with Sketch.  932  Views Created with Sketch.  419K 
TLX
News: TLX Telix Pharmaceuticals Submits A New Drug Application To U.S. FDA For TLX007-CDX
11:35 0 185
11:35 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  185 
TLX
MITA Applauds Introduction of the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023
23/05/24 5 3.2K
23/05/24 Last post  spnc Comments Created with Sketch.  5  Views Created with Sketch.  3.2K 
TLX 23/05/24 40 11K
23/05/24 Last post  spnc Comments Created with Sketch.  40  Views Created with Sketch.  11K 
TLX 23/05/24 5 2.4K
23/05/24 Last post  Werble Comments Created with Sketch.  5  Views Created with Sketch.  2.4K 
TLX 22/05/24 2 1.3K
22/05/24 Last post  Global123 Comments Created with Sketch.  2  Views Created with Sketch.  1.3K 

See All Discussions arrow Created with Sketch.

Timeline

Telix Submits NDA for New Prostate Cancer Imaging Agent
27 May 08:29
 
Becoming a substantial holder from MUFG
22 May 18:05
 
Telix Results of Annual General Meeting
22 May 14:31
 
Telix Annual General Meeting - Presentation
22 May 09:50
 
Telix Annual General Meeting - Chairman and CEO Addresses
22 May 09:49
 
Becoming a substantial holder
21 May 17:58
 
View More arrow Created with Sketch.
(20min delay)
Last
$15.89
Change
0.420(2.71%)
Mkt cap ! $5.309B
Open High Low Value Volume
$16.05 $16.28 $15.51 $16.00M 1.013M

Buyers (Bids)

No. Vol. Price($)
1 2000 $15.85
 

Sellers (Offers)

Price($) Vol. No.
$15.89 873 2
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
$15.84
  Change
0.420 ( 2.53 %)
Open High Low Volume
$16.09 $16.28 $15.51 98194
Last updated 15.59pm 27/05/2024 ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.